Showing results (11-20 of 269) with videos related to

Sort By:
Pageof 27
Clinical Nuclear Medicine|May 11, 2016
18F-NaF PET/CT Imaging of Brain MetastasesMatteo Salgarello, Gianluigi Lunardi, Alessandro Inno, et al.
Critical Reviews in Oncology/Hematology|April 16, 2021
Current treatment options for HER2-positive breast cancer patients with brain metastasesDaniele Galanti, Alessandro Inno, Maria La Vecchia, et al.
Drug Target Insights|October 16, 2023
First-line tepotinib for a very elderly patient with metastatic NSCLC harboring <i>MET</i> exon 14 skipping mutation and high PD-L1 expressionAlessandro Inno, Giuseppe Bogina, Giulio Settanni, et al.
Tumori|May 23, 2022
Adherence to oral hormonal anticancer agents in breast cancerStefania Gori, Alessandra Modena, Jennifer Foglietta, et al.
Tomography (Ann Arbor, Mich.)|March 27, 2024
Dual-Energy CT in Oncologic ImagingGiovanni Foti, Giorgio Ascenti, Andrea Agostini, et al.
Clinical Breast Cancer|August 27, 2016
Cardiotoxicity of Aromatase Inhibitors in Breast Cancer PatientsJennifer Foglietta, Alessandro Inno, Francesca de Iuliis, et al.
Translational Lung Cancer Research|June 15, 2026
Long-term outcomes of ALK inhibitors in metastatic <i>ALK</i>-positive non-small cell lung cancer: an updated indirect comparison using reconstructed patient-level dataAndrea Ossato, Vera Damuzzo, Luna Del Bono, et al.
Current Oncology Reports|April 5, 2023
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just MyocarditisAlessandro Inno, Luigi Tarantini, Iris Parrini, et al.
Frontiers in Cardiovascular Medicine|February 19, 2024
Risk of cardiovascular toxicity with combination of immune-checkpoint inhibitors and angiogenesis inhibitors: a meta-analysisAlessandro Inno, Antonello Veccia, Giorgio Madonia, et al.
Critical Reviews in Oncology/Hematology|May 7, 2018
When and how to treat women with HER2-positive, small (pT1a-b), node-negative breast cancer?Stefania Gori, Monica Turazza, Alessandra Modena, et al.
Pageof 27